Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$37,617,263,984
+$4,841,928,787 QoQ
Shares Held
149,488,412
-0.8% QoQ
Ownership
8.46%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#1
of 4,167 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Mar 31, 2026CallValue
$11,200,735
CallShares
51,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BlackRock, Inc. holds $263,330,305,956 across 19 Drug Manufacturers - General names. ABBV ranks #3 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
67,540,400 | $81,009,988,717 | |
| 2 | JNJ |
Johnson & Johnson
|
212,098,264 | $53,866,596,097 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
149,488,412 | $37,617,263,984 | |
| 4 | MRK |
Merck & Co., Inc.
|
226,999,837 | $29,169,479,049 | |
| 5 | AMGN |
Amgen Inc
|
49,362,016 | $17,874,973,223 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
121,844,108 | $15,393,784,591 | |
| 7 | PFE |
Pfizer Inc
|
529,670,433 | $12,754,464,016 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
180,384,994 | $10,393,783,345 |
All Filings in ABBV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,617,263,984 | 149,488,412 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $11,200,735 | 51,500 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $32,775,335,197 | 150,698,125 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $34,541,871,319 | 151,174,543 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $33,799,535,175 | 145,977,089 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $27,370,794,589 | 147,456,064 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $30,564,388,301 | 145,878,142 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $25,239,719,890 | 142,035,565 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $26,851,862,521 | 135,972,567 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||